Intuitive Surgical, Inc.
Intuitive Surgical Announces New Board Appointments and Proposal Outcomes
Summary
On April 25, 2024, Intuitive Surgical, Inc. announced changes to its board of directors and committee chairs, as well as the results of shareholder proposals voted on at the 2024 Annual Meeting of Stockholders. Lewis Chew was appointed to succeed Mark J. Rubash as Chair of the Audit Committee, and Jami Dover Nachtsheim was appointed to succeed Alan J. Levy, Ph.D., as Chair of the Governance and Nominating Committee. The meeting saw the election of eleven new members to the board, approval of executive compensation on an advisory basis, ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm, and approval of amendments to the 2010 Incentive Award Plan and the 2000 Employee Stock Purchase Plan. A proposal requesting a racial and gender pay gap report was rejected.
Get alerts for ISRG
Be first to know when Intuitive Surgical, Inc. files with the SEC.
Filing Categories
Exhibits (2)
Advertisement
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a pioneering company in the field of robotic-assisted, minimally invasive surgery. It is renowned for its development of the da Vinci Surgical System, which revolutionizes surgical procedures by enhancing precision, flexibility, and control beyond the physical capabilities of the human hand. The company's cornerstone product allows surgeons to perform complex surgeries through small incisions, which can lead to quicker patient recovery, reduced hospital stays, and lower complication rates. Operating predominantly in the healthcare sector, Intuitive Surgical serves a significant role in advancing surgical technology and improving patient outcomes. The company collaborates across diverse medical specialties, including urology, gynecology, and general surgery, to expand the applications and accessibility of its robust surgical systems. As an innovator in the medical device industry, Intuitive Surgical has a profound impact not only on surgical methodologies but also on the economic aspects of medical practices by potentially lowering surgical costs. It continues to shape the future of surgery with its commitment to enhancing robotic-assisted techniques.
Official SEC Documents
Advertisement